製品の概要

  • 製品名Anti-HLA D+DR+DQ antibody [35]
  • 製品の詳細
    Mouse monoclonal [35] to HLA D+DR+DQ
  • アプリケーション適用あり: IP, Flow Cyt, IHC-Frmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Tumour fragments created by injecting VLM cells, (syngeneic simian virus 40 (SV40)-transformed cell line) into a BALB/c mouse.

  • 特記事項Recommended growth conditions: DMEM 5% FCS

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • バッファーPreservative: None
    Constituents: PBS
  • Concentration information loading...
  • 精製度IgG fraction
  • ポリ/モノモノクローナル
  • クローン名35
  • ミエローマunknown
  • アイソタイプIgG3
  • 軽鎖の種類unknown
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab20177 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IP Use at an assay dependent concentration.
Flow Cyt Use at an assay dependent concentration. ab91537-Mouse monoclonal IgG3, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.

ターゲット情報

Anti-HLA D+DR+DQ antibody [35] (ab20177) 使用論文

This product has been referenced in:
  • Allen CA & Hogg N Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res 47:2919-23 (1987). Read more (PubMed: 3105871) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab20177.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"